A 26 kDa yeast DNA topoisomerase I fragment: crystallographic structure and mechanistic implications
- PMID: 8747458
- DOI: 10.1016/s0969-2126(01)00269-6
A 26 kDa yeast DNA topoisomerase I fragment: crystallographic structure and mechanistic implications
Abstract
Background: Type I DNA topoisomerases, divided mechanistically into two subfamilies, are ubiquitous enzymes that participate in replication and transcription. In addition to its role in these fundamental processes, the biological importance of eukaryotic DNA topoisomerase I is underscored by its identification as the target of the antitumor alkaloid camptothecin. An understanding of the mechanism of catalysis and interactions with camptothecin and other drugs has been hampered by a lack of detailed structural information.
Results: The three-dimensional structure of a 26 kDA fragment (residues 135 to about 363) of Saccharomyces cerevisiae DNA topoisomerase I has been determined at 1.9 A resolution. The fragment has a novel architecture comprising a concave platform and a pair of outlying V-shaped helices. Photocrosslinking and protein footprinting experiments show that the positively charged concave surface and the junction region of the V-shaped pair of helices contact DNA in the enzyme-DNA complex.
Conclusions: Crystallographic, biochemical and genetic data indicate that this 26 kDa fragment of yeast DNA topoisomerase I is involved in complex formation between the enzyme and DNA, and probably also in camptothecin-enzyme-DNA ternary complex formation. A molecular model for protein-DNA interaction based on these data is proposed. The bipartite DNA-binding regions of the 26 kDa fragment may enable eukaryotic DNA topoisomerase I to adapt to sequence-dependent structural variations in its DNA substrates.
Similar articles
-
DNA topoisomerase I domain interactions impact enzyme activity and sensitivity to camptothecin.J Biol Chem. 2015 May 8;290(19):12068-78. doi: 10.1074/jbc.M114.635078. Epub 2015 Mar 20. J Biol Chem. 2015. PMID: 25795777 Free PMC article.
-
Crystal structure of the amino-terminal fragment of vaccinia virus DNA topoisomerase I at 1.6 A resolution.Structure. 1994 Aug 15;2(8):767-77. doi: 10.1016/s0969-2126(94)00077-8. Structure. 1994. PMID: 7994576
-
Yeast Saccharomyces cerevisiae as a model system to study the cytotoxic activity of the antitumor drug camptothecin.Cancer Chemother Pharmacol. 1994;34 Suppl:S1-5. doi: 10.1007/BF00684856. Cancer Chemother Pharmacol. 1994. PMID: 8070016 Review.
-
Role for nucleolin/Nsr1 in the cellular localization of topoisomerase I.J Biol Chem. 2000 Nov 17;275(46):36181-8. doi: 10.1074/jbc.M006628200. J Biol Chem. 2000. PMID: 10967121
-
Recent developments in DNA topoisomerase II structure and mechanism.Curr Opin Struct Biol. 1996 Feb;6(1):84-90. doi: 10.1016/s0959-440x(96)80099-6. Curr Opin Struct Biol. 1996. PMID: 8696977 Review.
Cited by
-
Dimethylmyricacene: An In Vitro and In Silico Study of a Semisynthetic Non-Camptothecin Derivative Compound, Targeting Human DNA Topoisomerase 1B.Cells. 2022 Nov 3;11(21):3486. doi: 10.3390/cells11213486. Cells. 2022. PMID: 36359884 Free PMC article.
-
An insight into the active site of a type I DNA topoisomerase from the kinetoplastid protozoan Leishmania donovani.Nucleic Acids Res. 2002 Feb 1;30(3):794-802. doi: 10.1093/nar/30.3.794. Nucleic Acids Res. 2002. PMID: 11809893 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials